Jeanette A Stewart Selected Research

dorzolamide (Trusopt)

8/2008	A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
6/2008	Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy.
2/2008	Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
10/2007	The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression.
4/2005	24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
1/2004	[Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
8/2003	Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.
4/2003	Acute and chronic ocular symptoms of dorzolamide 2% compared with placebo.
2/2003	Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeanette A Stewart Research Topics

Disease

20	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2013 - 05/2002
14	Ocular Hypertension (Glaucoma, Suspect) 10/2011 - 05/2002
10	Glaucoma 01/2018 - 02/2009
5	Hyperemia 11/2010 - 05/2002
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2018 - 06/2010
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2015
2	Pain (Aches) 01/2004 - 04/2003
1	Macular Edema 01/2018
1	Low Vision (Subnormal Vision) 01/2004
1	Dizziness (Lightheadedness) 06/2002
1	Fatigue 06/2002

Drug/Important Bio-Agent (IBA)

14	Timolol (Blocadren)FDA LinkGeneric 01/2013 - 05/2002
10	Latanoprost (Xalatan)FDA Link 01/2013 - 03/2003
9	dorzolamide (Trusopt)FDA LinkGeneric 08/2008 - 02/2003
5	Travoprost (Travatan)FDA Link 11/2010 - 03/2003
4	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 04/2005 - 06/2002
3	Pharmaceutical PreparationsIBA 01/2018 - 07/2014
3	SolutionsIBA 10/2009 - 05/2002
3	Pilocarpine (Ocusert)FDA LinkGeneric 12/2008 - 08/2003
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 10/2011 - 09/2008
2	ProstaglandinsIBA 10/2011 - 09/2008
2	Bimatoprost (Lumigan)FDA Link 08/2008 - 03/2003
1	Hormones (Hormone)IBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	brinzolamide (Azopt)FDA Link 01/2012
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 11/2010
1	Fluorescein (Funduscein)FDA LinkGeneric 11/2010
1	Lubricant Eye Drops (Artificial Tears)IBA 06/2010
1	hydroxide ionIBA 12/2008

Therapy/Procedure

8	Therapeutics 01/2015 - 06/2003
3	Slit Lamp 10/2009 - 05/2002
1	Prostheses and Implants (Prosthesis) 01/2015
1	Molteno Implants 01/2010
1	Anesthesia 10/2009